Hospital Universitario de Donostia-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2010

  1. Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959

  2. Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 1, pp. 93-97

  3. Trichophyton rubrum syndrome: The tip of the iceberg and a preventable outcome

    Mycoses

2005

  1. Dermatofitosis con lesiones concurrentes a distancia. Importancia pronóstica y terapéutica

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 4, pp. 191-193

  2. In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease

    Clinical Infectious Diseases, Vol. 41, Núm. 4, pp. 560-564

2003

  1. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates

    Emerging Infectious Diseases, Vol. 9, Núm. 9, pp. 1159-1162

2002

  1. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

2001

  1. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 32, Núm. 11